Upgrade to SI Premium - Free Trial

Coherent, Inc. Reports Second Fiscal Quarter Results

April 29, 2015 4:01 PM

SANTA CLARA, Calif., April 29, 2015 /PRNewswire/ -- Coherent, Inc. (NASDAQ, COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its second fiscal quarter ended April 4, 2015.

FINANCIAL HIGHLIGHTS

Three Months Ended

Six Months Ended

April 4, 2015

December 27, 2014

March 29, 2014

April 4, 2015

March 29, 2014

GAAP Results

(in millions except per share data)

Bookings

$

220.6

$

162.5

$

261.8

$

383.1

$

463.3

Net sales

$

203.7

$

200.6

$

199.2

$

404.3

$

392.8

Net income

$

18.4

$

17.4

$

15.3

$

35.8

$

27.0

Diluted EPS

$

0.74

$

0.69

$

0.61

$

1.43

$

1.08

Non-GAAP Results

(in millions except per share data)

Net income

$

23.4

$

21.9

$

20.4

$

45.3

$

37.5

Diluted EPS

$

0.94

$

0.87

$

0.82

$

1.81

$

1.50

SECOND FISCAL QUARTER DETAILS

For the second fiscal quarter ended April 4, 2015, Coherent announced net sales of $203.7 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $18.4 million, or $0.74 per diluted share. These results compare to net sales of $199.2 million and net income of $15.3 million, or $0.61 per diluted share, for the second quarter of fiscal 2014.

Non-GAAP net income for the second quarter of fiscal 2015 was $23.4 million, or $0.94 per diluted share. Non-GAAP net income for the second quarter of fiscal 2014 was $20.4 million, or $0.82 per diluted share. Reconciliations of GAAP to non-GAAP financial measures for the three months ended April 4, 2015, December 27, 2014 and March 29, 2014 appear in the financial statements portion of this release under the heading "Reconciliation of GAAP to Non-GAAP net income."

Net sales for the first quarter of fiscal 2015 were $200.6 million and net income, on a GAAP basis, was $17.4 million, or $0.69 per diluted share. Non-GAAP net income for the first quarter of fiscal 2015 was $21.9 million, or $0.87 per diluted share.

Bookings received during the second fiscal quarter ended April 4, 2015 were $220.6 million. This result compares to bookings of $261.8 million in the same prior year period and $162.5 million in the immediately preceding quarter.

The book-to-bill ratio was 1.08, and ending backlog expected to ship in the next 12 months was $315.3 million at April 4, 2015, compared to a backlog of $295.9 million at December 27, 2014 and a backlog of $303.8 million at March 29, 2014.

"We are pleased by the solid results in our second quarter including the acceleration in demand across our commercial markets. Our FPD business picked up with new system and higher service orders. The outlook in FPD is strong and we expect a number of new system orders over the next few quarters," stated John Ambroseo, Coherent's President and Chief Executive Officer. "Orders in other commercial areas were very encouraging. The via drilling market continues to improve and we received multiple volume orders for our J-Series Hornet™ laser and have more opportunities on the horizon. The bioinstrumentation and medical OEM market posted record orders. Instrumentation customers' confidence grew and they reverted to longer-term purchases, primarily for our OBIS™ portfolio. The medical OEM market was very robust for ophthalmic (cataract and disease management), home-based aesthetic, dental and medical consumables (disposable fibers)," Ambroseo added.

Coherent ended the quarter with cash, cash equivalents and short term investments of $344.4 million, an increase of $21.5 million from cash, cash equivalents and short term investments of $323.0 million at December 27, 2014.

On July 25, 2014, the Board of Directors authorized a buyback program whereby the Company was authorized to repurchase up to $25.0 million of its common stock from time to time through July 31, 2015. During the first and second quarters of fiscal 2015, the Company repurchased and retired outstanding common stock for a total of $17.3 million and $7.7 million, respectively, completing this program.

On January 21, 2015, the Board of Directors authorized an additional stock repurchase program to repurchase up to $25 million of the Company's outstanding common stock through January 31, 2016. No repurchases have been made under this program to date.

CONFERENCE CALL REMINDER

The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at http://www.coherent.com/Investors/. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on the company's website. A transcript of management's prepared remarks can be found at http://www.coherent.com/Investors/.

Summarized statement of operations information is as follows (unaudited, in thousands except per share data):

Three Months Ended

Six Months Ended

April 4, 2015

December 27, 2014

March 29, 2014

April 4, 2015

March 29, 2014

Net Sales

$

203,721

$

200,615

$

199,222

$

404,336

$

392,778

Cost of sales(A)(B)(C)

120,417

118,296

118,557

238,713

234,567

Gross profit

83,304

82,319

80,665

165,623

158,211

Operating expenses:

Research & development(A)(B)

21,024

19,173

20,413

40,197

41,350

Selling, general & administrative(A)(B)

39,482

38,141

39,296

77,623

79,187

Amortization of intangible assets(C)

666

696

916

1,362

1,850

Total operating expenses

61,172

58,010

60,625

119,182

122,387

Income from operations

22,132

24,309

20,040

46,441

35,824

Other income (expense), net(B)

1,990

(685)

1,040

1,305

820

Income before income taxes

24,122

23,624

21,080

47,746

36,644

Provision for income taxes(D)

5,709

6,194

5,773

11,903

9,634

Net income

$

18,413

$

17,430

$

15,307

$

35,843

$

27,010

Net income per share:

Basic

$

0.75

$

0.70

$

0.62

$

1.44

$

1.10

Diluted

$

0.74

$

0.69

$

0.61

$

1.43

$

1.08

Shares used in computations:

Basic

24,709

24,936

24,782

24,823

24,662

Diluted

24,891

25,197

25,044

25,042

24,980

(A)

Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data):

Stock-related compensation expense

Three Months Ended

Six Months Ended

April 4, 2015

December 27, 2014

March 29, 2014

April 4, 2015

March 29, 2014

Cost of sales

$

676

$

597

$

648

$

1,273

$

1,186

Research & development

556

330

500

886

1,022

Selling, general & administrative

3,550

3,463

3,524

7,013

7,332

Impact on income from operations

$

4,782

$

4,390

$

4,672

$

9,172

$

9,540

For the quarters ended April 4, 2015, December 27, 2014 and March 29, 2014, the impact on net income, net of tax was $3,479 ($0.14 per diluted share), $3,960 ($0.16 per diluted share) and $3,346 ($0.13 per diluted share), respectively. For the six months ended April 4, 2015 and March 29, 2014, the impact on net income, net of tax was $7,439 ($0.30 per diluted share) and $6,875 ($0.28 per diluted share), respectively.

(B)

Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net. Deferred compensation expense (benefit) included in operating results is summarized below:

Deferred compensation expense

Three Months Ended

Six Months Ended

April 4, 2015

December 27, 2014

March 29, 2014

April 4, 2015

March 29, 2014

Cost of sales

$

21

$

14

$

29

$

35

$

97

Research & development

77

83

123

160

419

Selling, general & administrative

598

428

746

1,026

2,569

Impact on income from operations

$

696

$

525

$

898

$

1,221

$

3,085

For the quarters ended April 4, 2015, December 27, 2014 and March 29, 2014, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $724, $449 and $1,335, respectively. For the six months ended April 4, 2015 and March 29, 2014, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $1,173 and $3,266, respectively.

(C)

For the quarters ended April 4, 2015, December 27, 2014 and March 29, 2014, the impact of amortization of intangible assets was $2,036 ($1,540 net of tax ($0.06 per diluted share)), $2,180 ($1,607 net of tax ($0.06 per diluted share)) and $2,434 ($1,763 net of tax ($0.07 per diluted share)), respectively. For the six months ended April 4, 2015 and March 29, 2014, the impact of amortization of intangible assets was $4,216 ($3,147 net of tax ($0.13 per diluted share)) and $4,879 ($3,586 net of tax ($0.14 per diluted share)), respectively.

(D)

The quarter ended December 27, 2014 included $1,118 ($0.04 per diluted share) non-recurring tax benefit from the renewal of the R&D tax credit for fiscal 2014.

Summarized balance sheet information is as follows (unaudited, in thousands):

April 4, 2015

September 27, 2014

ASSETS

Current assets:

Cash, cash equivalents and short-term investments

$

344,434

$

318,275

Accounts receivable, net

124,227

137,324

Inventories

153,659

170,483

Prepaid expenses and other assets

62,370

54,973

Total current assets

684,690

681,055

Property and equipment, net

100,903

107,424

Other assets

189,400

210,896

Total assets

$

974,993

$

999,375

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

31,949

$

32,784

Other current liabilities

100,195

84,535

Total current liabilities

132,144

117,319

Other long-term liabilities

52,364

62,407

Total stockholders' equity

790,485

819,649

Total liabilities and stockholders' equity

$

974,993

$

999,375

Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands (other than per share data), net of tax):

Three Months Ended

Six Months Ended

April 4, 2015

December 27, 2014

March 29, 2014

April 4, 2015

March 29, 2014

GAAP net income

$

18,413

$

17,430

$

15,307

$

35,843

$

27,010

Stock-related compensation expense

3,479

3,960

3,346

7,439

6,875

Amortization of intangible assets

1,540

1,607

1,763

3,147

3,586

Non-recurring tax benefit

(1,118)

(1,118)

Non-GAAP net income

$

23,432

$

21,879

$

20,416

$

45,311

$

37,471

Non-GAAP net income per diluted share

$

0.94

$

0.87

$

0.82

$

1.81

$

1.50

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to the Company's outlook for our flat panel display market products, timing for orders, the Company's opportunities in the via drilling market and for future orders of the Company's products. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement. Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with any general market recovery, growth in demand for our products, the worldwide demand for flat panel displays, the demand for and use of the Company's products in commercial applications, our successful implementation of our customer design wins, our and our customers' exposure to risks associated with worldwide economic conditions, our customers' ability to cancel long-term purchase orders, the ability of our customers to forecast their own end markets, our ability to accurately forecast future periods, customer acceptance and adoption of our new product offerings, continued timely availability of products and materials from our suppliers, our ability to timely ship our products and our customers' ability to accept such shipments, our ability to have our customers qualify our product offerings, worldwide government economic policies and other risks identified in the Company's SEC filings. Readers are encouraged to refer to the risk disclosures and critical accounting policies and estimates described in the Company's reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company. Actual results, events and performance may differ materially from those presented herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Standard & Poor's SmallCap 600 Index and the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4110. For more information about Coherent, visit the Company's Web site at www.coherent.com for product and financial updates.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/coherent-inc-reports-second-fiscal-quarter-results-300074474.html

SOURCE Coherent, Inc.

Categories

Press Releases

Next Articles